United Therapeutics Corp (NASDAQ:UTHR)

100.50
Delayed Data
As of Sep 25
 +0.60 / +0.60%
Today’s Change
75.58
Today|||52-Week Range
127.79
+14.10%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$4.5B

Company Description

United Therapeutics Corp. operates as a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening diseases. It markets and sells commercial therapies to treat pulmonary arterial hypertension and high-risk neuroblastoma. The firm also involves in the research and development of new indications and delivery devices for its product, and for the organ transplantation-related technologies. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD.

Contact Information

United Therapeutics Corp.
1040 Spring Street
Silver Spring Maryland 20910
P:(301) 608-9292
Investor Relations:

Employees

Shareholders

Other institutional52.81%
Mutual fund holders44.60%
Individual stakeholders13.92%

Top Executives

Martine A. RothblattChairman & Chief Executive Officer
Michael Ian BenkowitzPresident & Chief Operating Officer
James Christopher EdgemondCFO, Treasurer & Principal Accounting Officer
Paul A. MahonSecretary, Executive VP & General Counsel
Dewey SteadmanHead-Investor Relations